News

July 1, 2016July 1, 2016

Type 2 Diabetes: Young Patients Lax with Medicating Show Signs of Depression

News

In a recent study published in the journal Diabetes Care, a team of researchers found that Type 2 diabetes medication adherence is not affected by age, sex, parental education, family ... Read more

June 29, 2016June 29, 2016

Researchers Find Type 2 Diabetes Associated with High Glucose Levels and Larger Waist Size

News, Type 2 Diabetes News

People with a larger waist circumference and higher glucose levels — but not those with abnormal plasma triglyceride, high-density lipoprotein cholesterol (HDL, the good cholesterol), or blood pressure levels — have ... Read more

June 27, 2016June 27, 2016

Manufactured Stem Cells Might Boost Development of New Diabetes Therapies

News, Type 1 Diabetes News, Type 2 Diabetes News

Induced pluripotent stem cells (iPSCs) can be generated from adult cells. Because iPSCs have the potential to develop into any cell type in the human body, they hold an enormous therapeutic potential in a ... Read more

June 24, 2016June 24, 2016

Type 2 Diabetes Patients Show Successful Switch to Toujeo in Real-World Setting

News

Sanofi recently released new positive real-world data reports evaluating Toujeo for patients with Type 2 diabetes. The results of the study were presented at the American Diabetes Association 76th Scientific Sessions, June 10 – 14, ... Read more

June 22, 2016June 22, 2016

Drug to Treat Type 2 Diabetes, Ertugliflozin, Reported to Effectively Lowers Blood Glucose Levels

insulin resistance, News, Type 2 Diabetes News

Merck (MSD), together with Pfizer, recently reported that the drug ertugliflozin is able to significantly decrease the average blood glucose levels (assessed as HbA1C) in patients with type 2 diabetes. The findings were obtained from two Phase ... Read more

June 21, 2016June 21, 2016

vTv Therapeutics Presents Positive Data on Pilot Study of Type 2 Diabetes Treatment

insulin resistance, News

vTv Therapeutics presented the findings of a pilot clinical study, now completed, evaluating TTP399, the company’s liver-selective glucokinase activator (GKA), an oral treatment being developed for patients with type 2 diabetes (T2D). Data were presented ... Read more

June 20, 2016June 20, 2016

Positive Data for Glytec’s Glucommander Presented to American Diabetes Association

News, Type 1 Diabetes News, Type 2 Diabetes News

Glytec, together with collaborators, presented five abstracts at the American Diabetes Association (ADA)’s 76th Scientific Sessions June 10-14 in New Orleans that focused on diabetes care, particularly in the way Glucommander software helps ... Read more

June 17, 2016June 17, 2016

Diabetes No Longer Interrupts Social Dining with New Mealtime Delivery Patch

insulin resistance, News, Type 1 Diabetes News, Type 2 Diabetes News

People with Type 1 and Type 2 diabetes using the One Touch Via delivery system had fewer missed insulin doses and less stress compared to multiple daily injections, according to data presented at ... Read more

June 15, 2016June 15, 2016

Promising Data on Diabetes Monitoring Reported at ADA Scientific Sessions

News

Ascencia Diabetes Care, a company specializing in blood glucose monitoring systems (BGMS), recently reported that data from three of their products were presented at the American Diabetes Association’s 76th Scientific ... Read more

June 13, 2016June 13, 2016

Alterations to Epigenome May Lead to Diabetes in Obese People, Researchers Say

insulin resistance, News, Type 2 Diabetes News

Excess weight is an established risk factor for developing type 2 diabetes, yet many obese people don’t develop the condition. Now, researchers at the Karolinska Institute in Sweden and the Institute of ... Read more